Novel peptides and combination of peptides for use in immunotherapy against various tumors
Номер патента: CA3111741A1
Опубликовано: 06-10-2016
Автор(ы): Andrea MAHR, Harpreet Singh, Jens FRITSCHE, Lea STEVERMANN, Oliver Schoor, Toni Weinschenk
Принадлежит: IMMATICS BIOTECHNOLOGIES GMBH
Опубликовано: 06-10-2016
Автор(ы): Andrea MAHR, Harpreet Singh, Jens FRITSCHE, Lea STEVERMANN, Oliver Schoor, Toni Weinschenk
Принадлежит: IMMATICS BIOTECHNOLOGIES GMBH
Реферат: Abstract The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules. Date Recue/Date Received 2021-03-10
New peptides and a new combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other types of cancer
Номер патента: ES2900106T3. Автор: Toni Weinschenk,Andrea MAHR,Jens FRITSCHE,Phillip Müller,Anita WIEBE,Sarah MISSEL. Владелец: IMMATICS BIOTECHNOLOGIES GMBH. Дата публикации: 2022-03-15.